Cytosorbents Corporation (CTSO)
NASDAQ: CTSO
· Real-Time Price · USD
1.22
0.04 (3.39%)
At close: Jun 27, 2025, 3:59 PM
1.23
1.23%
After-hours: Jun 27, 2025, 05:12 PM EDT
3.39% (1D)
| Bid | 1.16 |
| Market Cap | 76.07M |
| Revenue (ttm) | 27.66M |
| Net Income (ttm) | -15.84M |
| EPS (ttm) | -0.29 |
| PE Ratio (ttm) | -4.19 |
| Forward PE | -17.14 |
| Analyst | Hold |
| Ask | 1.5 |
| Volume | 91,207 |
| Avg. Volume (20D) | 107,446 |
| Open | 1.19 |
| Previous Close | 1.18 |
| Day's Range | 1.14 - 1.24 |
| 52-Week Range | 0.70 - 1.61 |
| Beta | 1.05 |
About CTSO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTSO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTSO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Cytosorbents Corporation is scheduled to release its earnings on Aug 12, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
8 months ago
-10%
CytoSorbents shares are trading lower. The company...
Unlock content with
Pro Subscription
11 months ago
+17.48%
Cytosorbents shares are trading higher after EF Hutton initiated coverage on the stock with a Buy rating and announced a price target of $10.
2 months ago · seekingalpha.com
Cytosorbents Corporation (CTSO) Q4 2024 Earnings Call TranscriptCytosorbents Corporation (NASDAQ:CTSO ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Adanna Alexander – IR Phillip Chan - CEO & Director Peter Mariani - CFO Conferen...